Copyright
©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2463-2467
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2463
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2463
Table 1 Carcinogenic factors involved in hepatocellular carcinoma in patients with type B cirrhosis[1]
| Variable | n | Univariate analysis | Multivariate analysis | ||||
| P-value1 | RR2 | 95% CI | P-value3 | RR2 | 95% CI | ||
| ALT (IU/L) | |||||||
| ≥ 100 | 14 | 0.0083 | 2.044 | 1.098-4.677 | 0.025 | 4.525 | 1.202-17.030 |
| < 100 | 51 | 1.000 | 1.000 | ||||
| LDH (IU/L) | |||||||
| ≥ 480 | 30 | 0.0138 | 2.000 | 0.878-4.558 | NS (0.081) | 2.880 | 0.881-9.412 |
| < 480 | 35 | 1.000 | 1.000 | ||||
| HBV-DNA (LGE/mL) | |||||||
| ≥ 3.7 | 46 | 0.0082 | 2.836 | 1.269-6.340 | 0.014 | 7.712 | 1.511-39.365 |
| < 3.7 | 19 | 1.000 | 1.000 | ||||
- Citation: Ishikawa T. Clinical features of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2010; 16(20): 2463-2467
- URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2463.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2463
